FastWave Medical today announced successful 30-day results from the first-in-human study of its intravascular lithotripsy (IVL) technology. Minneapolis-based FastWave develops laser-based IVL technology for treating calcific artery disease. Its platform offers durable and fast energy delivery with enhanced sonic output. The system helps to … [Read more...] about FastWave reports positive 30-day results in first-in-human IVL study
FastWave Medical
The top catheter-based innovation news stories of 2024 — so far
Catheter innovations have had a remarkable year so far, with many receiving regulatory approval as they prepare to enter the market. The pulsed field ablation market heated up in 2023 and continues to make waves this year with more companies entering the space. Intravascular lithotripsy is having its moment as well – Shockwave Medical was … [Read more...] about The top catheter-based innovation news stories of 2024 — so far
FastWave Medical kicks off first-in-human study of its IVL tech
FastWave Medical announced the successful completion of enrollment for its first-in-human study of its peripheral intravascular lithotripsy (IVL) system to treat calcified cardiovascular disease. Dr. Miguel Montero-Baker of Houston Methodist Hospital and the Hope Vascular & Podiatry Clinic and Dr. Venkatesh Ramaiah of HonorHealth Vascular … [Read more...] about FastWave Medical kicks off first-in-human study of its IVL tech
FastWave Medical closes Series Pre-A funding round, acquired by China Grand Pharmaceutical
FastWave Medical this week announced that it has closed its Series Pre-A financing round following its recent acquisition by China Grand Pharmaceutical and Healthcare Holdings. Minneapolis-based FastWave Medical, incubated by Big Sky Biomedical partners, earmarked the funds to advance research and development and to achieve key regulatory … [Read more...] about FastWave Medical closes Series Pre-A funding round, acquired by China Grand Pharmaceutical
